Clinical Trial Update: Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding 5-azacytidine to standard frontline therapy in elderly patients with newly diagnosed AML has completed. The update reports on ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)

Snippet

Sponsor: University Hospital Muenster | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED